Greater understanding of immune-related adverse events (irAE) could lead to new approaches in overcoming them. The authors show immunopathology of irAE dermatitis is dominated by Th1/Tc1 TRM cells, suggesting topical… Click to show full abstract
Greater understanding of immune-related adverse events (irAE) could lead to new approaches in overcoming them. The authors show immunopathology of irAE dermatitis is dominated by Th1/Tc1 TRM cells, suggesting topical JAK inhibitors as corticosteroid-sparing agents in cutaneous irAEs.
               
Click one of the above tabs to view related content.